A common hypertension treatment may reduce PTSD symptoms

There are currently only two FDA-approved medications for the treatment of posttraumatic stress disorder (PTSD) in the United States. Both of these medications are serotonin uptake inhibitors. Despite the availability of these medications, many people diagnosed with PTSD remain symptomatic, highlighting the need for new medications for PTSD treatment.

The renin-angiotensin system has long been of interest to psychiatry. Some of the first drugs targeting this system were the (ACE) inhibitors and angiotensin receptor blockers (ARBs), commonly prescribed treatments for .

In the 1990's, multicenter studies evaluating ACE inhibitors suggested that they improved quality of life as well as other medical outcomes, but these medications did not prove to be sufficiently effective for the treatment of psychiatric disorders to become established treatments.

Recently, however, investigators at Emory University observed that individuals diagnosed with PTSD, and who happened to also be treated with ARBs or ACE inhibitors, exhibited fewer PTSD-like symptoms.

This led the researchers to investigate the underlying mechanisms using an animal model of PTSD in order to expand upon this clinical finding.

Dr. Paul Marvar, first author and Assistant Professor at The George Washington University, explains their findings, "Our current preclinical results show that the ARB losartan, given acutely or chronically to mice, enhances the extinction of fear memory, a process that is disrupted in individuals with PTSD. Overall these data provide further support that this class of medications may have beneficial effects on in PTSD patients."

Fear extinction is a process by which a memory associated with fear is gradually 'overwritten' in the brain by a new memory with no such association. For example, exposure therapy is a form of , whereby repeatedly exposing a patient in a safe manner to a feared object or situation slowly reduces or eliminates their fear. A medication that could potentially enhance the extinction of fear would be welcome to the millions of individuals who continue to suffer with symptoms of PTSD.

"It is exciting to see the renin-angiotensin being explored in new ways in the search for new treatment for PTSD," commented Dr. John Krystal, Editor of Biological Psychiatry. "There is a tremendous need for more effective treatments for PTSD symptoms."

Future studies are still necessary before clinical use could be recommended, but there is hope that by targeting this pathway, it may provide a safe and powerful adjunctive novel therapy for the treatment of PTSD.

More information: The article is "Angiotensin Type 1 Receptor Inhibition Enhances the Extinction of Fear Memory" by Paul J. Marvar, Jared Goodman, Sebastien Fuchs, Dennis C. Choi, Sunayana Banerjee, Kerry J. Ressler (DOI: 10.1016/j.biopsych.2013.08.024). The article appears in Biological Psychiatry, Volume 75, Issue 11 (June 1, 2014)

add to favorites email to friend print save as pdf

Related Stories

Study examines ties between alcohol and PTSD

May 16, 2014

Alcohol abuse occurs in 52% of men and 28% of women with posttraumatic stress disorder (PTSD). Comorbid alcoholism and PTSD leads more frequently to low income, unemployment, and overall social dysfunction than either condition ...

Can smoking medical marijuana reduce PTSD symptoms?

May 23, 2014

Clinical research from New Mexico supports a conclusion that smoking cannabis [marijuana] is associated with PTSD symptom reduction in some patients. The study, published in the newest special issue of Journal of Psychoactive ...

PTSD psychotherapy is enhanced with D-cycloserine

Jun 04, 2012

Posttraumatic stress disorder (PTSD) is among the most common, distressing, and disabling medical consequences of combat or other extremely stressful life events. The first-line treatment for PTSD is exposure therapy, a type ...

Recommended for you

Web technology offers mental health support

52 minutes ago

A web based application connecting people with potential mental health issues to clinical advice and support networks has been created by researchers at Aston and Warwick universities.

Researchers urge psychologists to see institutional betrayal

16 hours ago

Clinical psychologists are being urged by two University of Oregon researchers to recognize the experiences of institutional betrayal so they can better treat their patients and respond in ways that help avoid or repair damaged ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

jeff_eastman_543
not rated yet Jun 11, 2014
"22 veterans commit suicide every day. 46 attempt suicide."

A new anonymous online computer therapy program for PTSD at PTSDSTRESS.COM reduces the symptoms of PTSD.

The user follows an easy-to-use program on their home computer. Military and non-military men and women have used it for over 5 years. Results are at www.PTSDSTRESS.com.

The program is anonymous and requires no registration. The cost is $10 per session and accepts credit cards but does not require a cardholder name for further confidentiality. Military and non-military men and women users including victims of trauma like sexual assault report results on PTSDSTRESS.COM home page.